ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2019

An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?

Xu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.